PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WIRE vs. BMY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WIRE and BMY is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

WIRE vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February0
18.64%
WIRE
BMY

Key characteristics

Fundamentals

Market Cap

WIRE:

$4.58B

BMY:

$113.30B

EPS

WIRE:

$19.04

BMY:

-$4.41

PEG Ratio

WIRE:

2.09

BMY:

1.26

Total Revenue (TTM)

WIRE:

$632.66M

BMY:

$48.30B

Gross Profit (TTM)

WIRE:

$135.99M

BMY:

$32.20B

EBITDA (TTM)

WIRE:

$83.43M

BMY:

$3.16B

Returns By Period


WIRE

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

BMY

YTD

-0.20%

1M

-2.21%

6M

18.64%

1Y

14.20%

5Y*

0.38%

10Y*

2.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WIRE vs. BMY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WIRE
The Risk-Adjusted Performance Rank of WIRE is 9595
Overall Rank
The Sharpe Ratio Rank of WIRE is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of WIRE is 9494
Sortino Ratio Rank
The Omega Ratio Rank of WIRE is 9292
Omega Ratio Rank
The Calmar Ratio Rank of WIRE is 9797
Calmar Ratio Rank
The Martin Ratio Rank of WIRE is 9696
Martin Ratio Rank

BMY
The Risk-Adjusted Performance Rank of BMY is 6363
Overall Rank
The Sharpe Ratio Rank of BMY is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of BMY is 6262
Sortino Ratio Rank
The Omega Ratio Rank of BMY is 6060
Omega Ratio Rank
The Calmar Ratio Rank of BMY is 6262
Calmar Ratio Rank
The Martin Ratio Rank of BMY is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WIRE vs. BMY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WIRE, currently valued at 1.80, compared to the broader market-2.000.002.001.800.60
The chart of Sortino ratio for WIRE, currently valued at 3.63, compared to the broader market-4.00-2.000.002.004.006.003.631.12
The chart of Omega ratio for WIRE, currently valued at 1.94, compared to the broader market0.501.001.502.001.941.14
The chart of Calmar ratio for WIRE, currently valued at 2.72, compared to the broader market0.002.004.006.002.720.37
The chart of Martin ratio for WIRE, currently valued at 15.67, compared to the broader market-10.000.0010.0020.0030.0015.671.51
WIRE
BMY


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.80
0.60
WIRE
BMY

Dividends

WIRE vs. BMY - Dividend Comparison

WIRE has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.33%.


TTM20242023202220212020201920182017201620152014
WIRE
Encore Wire Corporation
0.01%0.02%0.04%0.06%0.04%0.17%0.14%0.16%0.16%0.18%0.16%0.21%
BMY
Bristol-Myers Squibb Company
4.33%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%

Drawdowns

WIRE vs. BMY - Drawdown Comparison


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-0.48%
-24.30%
WIRE
BMY

Volatility

WIRE vs. BMY - Volatility Comparison

The current volatility for Encore Wire Corporation (WIRE) is 0.00%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.69%. This indicates that WIRE experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February0
8.69%
WIRE
BMY

Financials

WIRE vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Encore Wire Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab